| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |